6
Oct
2026

NTC S.r.l.

Exhibitor at CPHI Milan 2026 stand 20H42, Finished Dosage & Formulation
About Us

NTC is an international R&D-driven pharmaceutical company headquartered in Milan, Italy, with distributors and partners in over 100 countries in the world, engaged in research, development, registration and commercialization of drugs, medical devices, and food supplements in ophthalmology, but also in other therapeutic areas like gastro-metabolism, gynecology, and pediatrics.

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20H42, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • NEW IMPERIAL LINE (OPHTHALMOLOGY, PERFECT DROP CONTROL, DRY EYE)

    Product NEW IMPERIAL LINE (OPHTHALMOLOGY, PERFECT DROP CONTROL, DRY EYE)

    Iridya system is a multidose preservative free device, with advanced ergonomics, drop control, microbiological safety and flexible viscosity adjustment, with “no jet” technology.

    From the combination of the moisturizing and protective qualities of Sodium Hyaluronate with the technological adva...
  • PROTECTORIAL/PURO PROTECT - Isotonic ointment with Hyaluronic Acid 0.4% (Ophthalmology - Dry Eye)

    Product PROTECTORIAL/PURO PROTECT - Isotonic ointment with Hyaluronic Acid 0.4% (Ophthalmology - Dry Eye)

    First in class ointment in the market enriched with Hyaluronic Acid. This product, thanks to Hyaluronic Acid and its isotonic characteristic, has been specifically formulated to offer effective symptoms relief for patients suffering from moderate to severe dry eye, kerato-conjunctivitis sicca and noct...
  • PURO EPITHEL - Carbomer + Dexpanthenol (Ophthalmology - Dry Eye)

    Product PURO EPITHEL - Carbomer + Dexpanthenol (Ophthalmology - Dry Eye)

    Specifically formulated to offer effective symptoms relief for patients suffering from dry eye syndrome and to stimulate epithelial corneal reparation in case of corneal erosion, burns, after ocular surgery (cataract and refractive) and in prolonged use of contact lenses .

    Ophthalmic gel...
  • SORGYVA - HYALURONIC ACID 0.2% WITH AMINOACIDS PRESERVATIVE FREE (OPHTHALMOLOGY – DRY EYE) - EYE DROP

    Product SORGYVA - HYALURONIC ACID 0.2% WITH AMINOACIDS PRESERVATIVE FREE (OPHTHALMOLOGY – DRY EYE) - EYE DROP

    Aminoacids stabilize sodium hyaluronate viscosity during blinking, ensuring its distribution and adhesion onto the corneal surface and favouring its hydrating and protective effect. Synergy between Aminoacids and Sodium Hyaluronate leads to tear film stability and corneal reparation. Preservative f...
  • BLEFASTOP (Ophthalmology - Blepharitis)

    Product BLEFASTOP (Ophthalmology - Blepharitis)

    The product has been specifically formulated as an adjuvant in blepharitis treatment. This product contains a derivative of Tea Tree Oil (Terpinen-4-ol) characterized by an anti-inflammatory, antimicrobial and acaricidal activity against Staphylococcus aureus and Demodex (either directly or by carrying...

NTC S.r.l. Resources (1)

  • Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.